Early mepolizumab initiation during remission induction is associated with lower organ damage burden in EGPA: a multicentre cohort study.

Maruyama A, Ono N, Kai T, Kimoto Y, Nakano M, Inoue Y, Ueda N, Miyamura T, Otsuka K, Shinkawa Y, Tada Y, Akahoshi M, Niiro H

Open source

DOI: 10.1093/rheumatology/keag523
Published: 2026 Sep 21
Container: Rheumatology (Oxford, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag523,
  title = {Early mepolizumab initiation during remission induction is associated with lower organ damage burden in EGPA: a multicentre cohort study.},
  author = {Maruyama A and Ono N and Kai T and Kimoto Y and Nakano M and Inoue Y and Ueda N and Miyamura T and Otsuka K and Shinkawa Y and Tada Y and Akahoshi M and Niiro H},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag523},
  url = {https://doi.org/10.1093/rheumatology/keag523}
}

RIS

TY  - JOUR
TI  - Early mepolizumab initiation during remission induction is associated with lower organ damage burden in EGPA: a multicentre cohort study.
AU  - Maruyama A
AU  - Ono N
AU  - Kai T
AU  - Kimoto Y
AU  - Nakano M
AU  - Inoue Y
AU  - Ueda N
AU  - Miyamura T
AU  - Otsuka K
AU  - Shinkawa Y
AU  - Tada Y
AU  - Akahoshi M
AU  - Niiro H
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag523
UR  - https://doi.org/10.1093/rheumatology/keag523
ER  -

APA

A, M., N, O., T, K., Y, K., M, N., Y, I., N, U., T, M., K, O., Y, S., Y, T., M, A., & H, N. (2026). Early mepolizumab initiation during remission induction is associated with lower organ damage burden in EGPA: a multicentre cohort study.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag523

Source records

pubmed · retrieved 2026-09-26T14:16:15.583Z